ClinicalTrials.gg
CompletedNCT07241507Updated Nov 21, 2025

Effect of Continuous Versus Interrupted Suturing on Wound Dehiscence and Infection After Abdominal Surgery

An interventional study of Continuous suturing and Interrupted suturing in Laparotomy Closure After Abdominal Surgery, Wound Infection, Surgical and Dehiscence of Laparotomy Wound, sponsored by Allama Iqbal Teaching Hospital. Completed at 1 site in Pakistan. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2025-11-21.

Sponsored by Allama Iqbal Teaching Hospital · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Registered 1 year 2 months after the study started (first participant enrolled Sep 2024, registered Nov 2025).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 25 studies in Surgical Wound Infection with a site in Pakistan — 6 open to participants now, 8 under way, 2 of them phase 3. Surgical Wound Infection · Pakistan.

Enrollment
20th of 24
80 · median 114
Started
2024
with 4 others
No phase
20 of 25
5 open now
Registered
12th of 25
by date
Lead sponsor
1 of 25
Allama Iqbal Teaching Hospital

Among the 25 studies in Surgical Wound Infection with a site in Pakistan, this one is the 20th largest by enrollment of the 24 interventional ones that give a count, is one of 5 that started in 2024, is one of 20 with no phase, and was the 12th registered.

Surgical Wound Infection

747 studies on the registry are indexed under Surgical Wound Infection; 152 are open to participants now.

Browse Surgical Wound Infection studies →

Open to participants now

6 of the 25 studies in Surgical Wound Infection with a site in Pakistan are open now. Recruiting first, the newest first:

1 more — sign in →

All 6 open studies →

A study can be open while its sites in Pakistan have not opened yet or have stopped. Only those recruiting at a site in Pakistan →

Who these studies take

Of the 85 Surgical Wound Infection studies recruiting now, 62 (73%) set no upper age limit and 16 (19%) stop at 75 or younger; 12 take children under 18; 14 take healthy volunteers.

This study: 18 Years to 60 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 25 studies in Surgical Wound Infection with a site in Pakistan, or all of them as a file.
02

Study summary

The goal of this clinical trial is to learn whether the type of suturing technique used to close the abdomen after exploratory laparotomy affects the rate of wound complications. Specifically, the study aims to find out if using interrupted sutures results in fewer cases of wound dehiscence (wound reopening) compared to continuous sutures.

The main question the study seeks to answer is:

Does interrupted suturing reduce the frequency of wound dehiscence compared to continuous suturing in patients undergoing exploratory laparotomy?

Researchers will also observe and compare wound infection rates between the two suturing methods.

About 80 adult patients (18-60 years old) undergoing exploratory laparotomy at the Department of General Surgery, DHQ Teaching Hospital, Dera Ghazi Khan, will take part in this study. Participants will be randomly assigned to one of two groups:

Group A: Continuous abdominal closure using No. 1 Vicryl suture

Group B: Interrupted abdominal closure using No. 1 Vicryl suture

All participants will have their baseline characteristics recorded, including age, gender, obesity, diabetes, and smoking status. The surgical technique and postoperative care will follow the hospital's standard protocols. After surgery, patients will be followed for four weeks with weekly clinical assessments to check for wound infection or wound dehiscence.

The hypothesis is that patients whose abdominal wounds are closed with interrupted sutures will have a lower frequency of wound dehiscence compared to those with continuous sutures.

The findings will help guide surgeons on which abdominal closure method provides better wound healing and fewer postoperative complications.

03

Conditions studied

  • Laparotomy Closure After Abdominal Surgery
  • Wound Infection, Surgical
  • Dehiscence of Laparotomy Wound
  • Suture, Interrupted
  • Continuous Suture

Keywords

  • exploratory laparotomy
  • Surgical wound infection
  • Wound dehiscence
04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Undergoing exploratory laparotomy
  • Both emergency and elective

Exclusion criteria

Exclusion Criteria:

  • Patients undergoing second laparotomy or re- laparotomy
  • Patients on therapy (assessed on medical record review)
  • Patients who die within 28-days of surgery
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (actual)

Study arms

  • Active comparator
    Group A - Continuous

    Continuous Suture

    Procedure: Continuous suturing

  • Experimental
    Group B - Interrupted

    Interrupted Suture

    Procedure: Interrupted suturing

Interventions

  • ProcedureContinuous suturing

    After an exploratory laparotomy continuous suturing using a single thread of Vicryl No. 1 will be used to stitch the incision's fascial layer together, 1 cm distance from wound edges and between each stitch, creating a line of even tension across the wound.

  • ProcedureInterrupted suturing

    After an exploratory laparotomy, interrupted suturing using a single thread of Vicryl No. 1 will be used to stitch the incision's fascial layer together, 1 cm distance from wound edges and between each stitch. A knot will be tied after each suture is passed through the tissue, and each stitch will be secured with its own knot.

06

What researchers measure

Primary outcomes

  1. Wound Dehiscence

    A partial or total separation of previously approximated wound edges, on clinical examination of surgical wound.

    Time frame: From enrollment to 28-days of operation

Other outcomes

  1. Surgical Wound Infection

    Presence any features of erythema, pain, pus discharge on examination of surgical wound and new onset fever (\> 98.60F)

    Time frame: From enrollment to 28-days after operation

07

Study locations

1 site
  • Allama Iqbal Teaching Hospital, Dera Ghazi Khan
    Dera Ghazi Khan, Punjab Province 32200, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2024 to primary completion in Mar 2025, 5 months.

Of 202 non-industry interventional studies with no phase under Surgical Wound Infection, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 47. This study's 5 months is below that.

Counting every sponsor, half of 209 studies reached it within 24 months; a quarter within 12 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 17, 2025
First posted
Nov 21, 2025
StartActual
Sep 11, 2024
Primary completionActual
Mar 10, 2025
CompletionActual
Mar 10, 2025
Last update
Nov 21, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 21, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07241507
Lead sponsor
Allama Iqbal Teaching Hospital
Responsible party
Muhammad Shehroz Sarwar (Principal Investigator, Allama Iqbal Teaching Hospital) — Principal investigator
First posted
Nov 21, 2025
Start date
Sep 11, 2024
Primary completion
Mar 10, 2025
Completion
Mar 10, 2025
Last update
Nov 21, 2025

Study contacts

Malik N Fareed, FCPS
study chair · Allama Iqbal Teaching Hospital Dera Ghazi Khan

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion